Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

1. Rivera, F.
2. Izquierdo-Manuel, M.
3. García-Alfonso, P.
4. Martínez de Castro, E.
5. Gallego, J.
6. Limón, M.L.
7. Alsina, M.
8. López, L.
9. Galán, M.
10. Falcó, E.
11. Manzano, J.L.
12. González, E.
13. Muñoz-Unceta, N.
14. López, C.
15. Aranda, E.
16. Fernández, E.
17. Jorge, M.
18. Jiménez-Fonseca, P.